相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Duality of Netherton syndrome manifestations and response to ixekizumab
Claire Barbieux et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling
K. Suessmuth et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin
Zhen Zhang et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2021)
Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome
Chiaki Murase et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2021)
Infliximab therapy in an infant with Netherton Syndrome
Fatih Cicek et al.
PEDIATRIC DERMATOLOGY (2021)
Netherton Syndrome in Children: Management and Future Perspectives
Federica Barbati et al.
FRONTIERS IN PEDIATRICS (2021)
Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency
Kira Stuvel et al.
ALLERGY (2020)
Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl
S. Volc et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses - a retrospective analysis
I. Luchsinger et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Successful treatment with dupilumab of an adult with Netherton syndrome
T. H. Andreasen et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Treatment of Netherton Syndrome With Dupilumab
Alexa B. Steuer et al.
JAMA DERMATOLOGY (2020)
Secukinumab Therapy for Netherton Syndrome
Isabelle Luchsinger et al.
JAMA DERMATOLOGY (2020)
Managing syndromic congenital ichthyosis at a tertiary care institute-Genotype-phenotype correlations, and novel treatments
Garima Dabas et al.
DERMATOLOGIC THERAPY (2020)
A novelSPINK5mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome
Maria Zelieskova et al.
PEDIATRIC DERMATOLOGY (2020)
Netherton syndrome: Temporary response to dupilumab
Meryem Aktas et al.
PEDIATRIC DERMATOLOGY (2020)
Advances in understanding of Netherton syndrome and therapeutic implications
Evgeniya Petrova et al.
EXPERT OPINION ON ORPHAN DRUGS (2020)
Netherton syndrome; neuropsychological and psychosocial functioning of child and adult patients and their parents
Josette J. W. M. Versteegh et al.
JOURNAL OF HEALTH PSYCHOLOGY (2020)
Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature
Kunal Malik et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Burden of itch in ichthyosis: a multicentre study in 94 patients
A. M. De Palma et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C
Kemal Ozyurt et al.
TURKISH JOURNAL OF PEDIATRICS (2019)
Alitretinoin reduces erythema in inherited ichthyosis
Giuliana Onnis et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Immune cell phenotype and functional defects in Netherton syndrome
Elina Eraenkoe et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
An 8-Year-Old Child with Delayed Diagnosis of Netherton Syndrome
Alexander K. C. Leung et al.
CASE REPORTS IN PEDIATRICS (2018)
Netherton Syndrome: A Genotype-Phenotype Review
Constantina A. Sarri et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Update on the use of immunoglobulin in human disease: A review of evidence
Elena E. Perez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis
Amy S. Paller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases
Deirdre De Ranieri et al.
PEDIATRIC ANNALS (2017)
A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels
Arzu Didem Yalcin
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Netherton Syndrome Mimicking Pustular Psoriasis: Clinical Implications and Response to Intravenous Immunoglobulin
Alison M. Small et al.
PEDIATRIC DERMATOLOGY (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Immunoglobulin Replacement Therapy for Primary Immunodeficiency
Panida Sriaroon et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2015)
Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015
Capucine Picard et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Methodology of clinical trials for rare diseases
Catrin Tudur Smith et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2014)
Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome
Tomoko Konishi et al.
JOURNAL OF DERMATOLOGY (2014)
Netherton syndrome: skin inflammation and allergy by loss of protease inhibition
Alain Hovnanian
CELL AND TISSUE RESEARCH (2013)
Care of the newborn with ichthyosis
Jonathan A. Dyer et al.
DERMATOLOGIC THERAPY (2013)
Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome
I. Maatouk et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Two Infants
Joel L. Gallagher et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
S. V. Kaveri et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Proteolytic Activation Cascade of the Netherton Syndrome-Defective Protein, LEKTI, in the Epidermis: Implications for Skin Homeostasis
Paola Fortugno et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Infliximab Infusions for Netherton Syndrome: Sustained Clinical Improvement Correlates with a Reduction of Thymic Stromal Lymphopoietin Levels in the Skin
Lionel Fontao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
The Safety and Efficacy of Pimecrolimus, 1%, Cream for the Treatment of Netherton Syndrome
Albert C. Yan et al.
ARCHIVES OF DERMATOLOGY (2010)
Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing
Chrystelle Bonnart et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Par2 Inactivation Inhibits Early Production of TSLP, but Not Cutaneous Inflammation, in Netherton Syndrome Adult Mouse Model
Anais Briot et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases
Ulf Meyer-Hoffert
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Comel-Netherton syndrome defined as primary immunodeficiency
Ellen D. Renner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Netherton's syndrome: successful treatment with isotretinoin
E. Lazaridou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Caspase-1 activity of stratum corneum and serum interleukin-18 level are increased in patients with Netherton syndrome
N. Hosomi et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control I desquamation through a pH-dependent interaction
Celine Deraison et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders
Hakan M. Gurcan et al.
ANNALS OF PHARMACOTHERAPY (2007)
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation
Carla A. Borgono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome
Jean-Pierre Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome
Pascal Descargues et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI Isoforms derived from alternative pre-mRNA processing
Alessandro Tartaglia-Polcini et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6
T Egelrud et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI)
NM Schechter et al.
BIOLOGICAL CHEMISTRY (2005)
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
D Czock et al.
CLINICAL PHARMACOKINETICS (2005)
Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity
P Descargues et al.
NATURE GENETICS (2005)
Generalized exfoliative erythroderma since birth
L El Shabrawi-Caelen et al.
ARCHIVES OF DERMATOLOGY (2004)
LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome
E Bitoun et al.
HUMAN MOLECULAR GENETICS (2003)
Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: A kinetic analysis
K Mitsudo et al.
BIOCHEMISTRY (2003)
Netherton syndrome:: Disease expression and spectrum of SPINK5 mutations in 21 families
E Bitoun et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Clinico-immunological heterogeneity in Comel-Netherton syndrome
D Van Gysel et al.
DERMATOLOGY (2001)
Neonatal and infantile erythrodermas -: A retrospective study of 51 patients
A Pruszkowski et al.
ARCHIVES OF DERMATOLOGY (2000)
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome
S Chavanas et al.
NATURE GENETICS (2000)
Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping
S Chavanas et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
